Actively Recruiting

All Genders
ID05720936

A Multicenter Observational Study on In-hospital Stellate Ganglion Block for Arrhythmic Storm

Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-06-08

500

Participants Needed

38

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying patients experiencing arrhythmic storm, a serious heart condition characterized by frequent and sustained ventricular arrhythmias that do not respond to standard antiarrhythmic drugs. This international multicenter observational study aims to evaluate the safety and effectiveness of Percutaneous Stellate Ganglion Block (PSGB) in reducing arrhythmic relapses in such emergency cases. The study is coordinated by Fondazione IRCCS Policlinico San Matteo of Pavia, Italy, and addresses a gap in large-scale data on this procedure. Participants who meet the criteria will receive PSGB using either the anatomical or echo-guided approach. Depending on patient needs, the procedure may involve a single anesthetic injection or continuous anesthetic infusion via a catheter connected to a pump. The study compares the number of arrhythmic events and defibrillations before and after PSGB treatment and notes any complications occurring within 12 hours post-procedure. During participation, patients will be monitored closely for arrhythmic relapses using defibrillation counts and anti-tachycardia pacing data. Complications such as hematomas, vascular injuries, and nerve damage will be recorded. Data are collected using a secure electronic system, with effectiveness measured by arrhythmic event reduction in the 12 hours following PSGB compared to the 12 hours prior. The study plans to enroll patients over several years with ongoing safety and outcome evaluations.

CONDITIONS

Brief Title

In-hospital Stellate Ganglion Block for Arrhythmic Storm

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Presence of arrhythmic storm defined as more than three sustained ventricular arrhythmias in 24 hours refractory to standard medical treatment
Not Eligible

You will not qualify if you...

  • Previous history of cardiac sympathicectomy
  • Neck unsuitable for the procedure due to previous neck surgery, burns, large scars, or thyroid goiter

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Procedure and up to 12 hours post-procedure

Participants undergo the percutaneous stellate ganglion block (PSGB) procedure using either the anatomical or echo-guided approach. The procedure involves either a single injection or continuous infusion of anesthetic.

1 procedure visit and monitoring for 12 hours afterward

Monitoring

Duration - 12 hours post-implementation

Participants are observed for effectiveness and complications related to the PSGB procedure, including arrhythmic relapse reduction and any procedure-related adverse events within 12 hours after the procedure.

Continuous monitoring during the 12 hours after the procedure

Trial Site Locations

Total: 38 locations

1

A.O. SS. Antonio e Biagio e Cesare Arrigo di Alessandria.

Alessandria, AL, Italy

Actively Recruiting

2

Ospedale di Bentivoglio

Bentivoglio, BO, Italy

Actively Recruiting

3

Ospedale Maggiore di Bologna

Bologna, BO, Italy

Actively Recruiting

4

Cardiology Department, Fondazione IRCCS Policlinico San Matteo

Pavia, PV, Italy, 27100

Actively Recruiting

5

Ospedale Civile

Voghera, PV, Italy

Actively Recruiting

6

Ospedale Mater Salutis

Legnago, VR, Italy

Actively Recruiting

7

A.O.U. delle Marche, Ospedali Riuniti

Ancona, Italy

Actively Recruiting

8

Ospedale Cardinal Massaia

Asti, Italy

Actively Recruiting

9

Policlinico S. Orsola-Malpighi, IRCCS A.O.U. Bologna

Bologna, Italy

Actively Recruiting

10

P.O. "San Michele" dell'ARNAS "G. Brotzu" di Cagliari

Cagliari, Italy

Actively Recruiting

11

Istituto clinico Humanitas Mater Domini di Castellanza

Castellanza, Italy

Actively Recruiting

12

Ospedale Maggiore

Crema, Italy

Actively Recruiting

13

Ospedale San Biagio di Domodossola

Domodossola, Italy

Actively Recruiting

14

Ospedale S. Maria Annunziata

Florence, Italy

Actively Recruiting

15

P.O. Santa Maria Nuova e Palagi

Florence, Italy

Actively Recruiting

16

Ospedale Misericordia di Grosseto.

Grosseto, Italy

Actively Recruiting

17

Ospedale di Gubbio-Gualdo Tadino, USL Umbria 1

Gubbio, Italy

Actively Recruiting

18

Ospedale Civile di Ivrea

Ivrea, Italy

Actively Recruiting

19

Ospedale Alessandro Manzoni

Lecco, Italy

Actively Recruiting

20

Azienda USL Toscana Nord Ovest, Presidio di Livorno

Livorno, Italy

Actively Recruiting

21

A.O.U. Policlinico "G. Martino" di Messina.

Messina, Italy

Actively Recruiting

22

ASST Santi Paolo e Carlo

Milan, Italy

Actively Recruiting

23

IRCCS Ospedale San Raffaele

Milan, Italy

Actively Recruiting

24

Istituto Auxologico Italiano

Milan, Italy

Actively Recruiting

25

ASST Grande Ospedale Metropolitano Niguarda di Milano

Milan, Italy

Actively Recruiting

26

Ospedale V. Monaldi - AOS dei Colli

Naples, Italy

Actively Recruiting

27

A.O.U. Maggiore della Carità di Novara

Novara, Italy

Actively Recruiting

28

Azienda Ospedale Università Padova

Padova, Italy

Actively Recruiting

29

Ospedale S. Maria della Misericordia - Perugia

Perugia, Italy

Actively Recruiting

30

Ospedale "Infermi" AUSL Romagna

Rimini, Italy

Actively Recruiting

31

A.O.U. Ospedale Sant'Andrea

Roma, Italy

Actively Recruiting

32

Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore

Roma, Italy

Actively Recruiting

33

Fondazione PTV Policlinico Tor Vergata di Roma

Roma, Italy

Actively Recruiting

34

Ospedale Fatebenefratelli di Roma.

Roma, Italy

Active, Not Recruiting

35

Ospedale San Paolo

Savona, Italy

Actively Recruiting

36

Ospedale Molinette di Torino

Torino, Italy

Actively Recruiting

37

Azienda Ospedaliera Universitaria Integrata - Verona

Verona, Italy

Actively Recruiting

38

Istituto Cardiocentro Ticino

Lugano, Switzerland

Active, Not Recruiting

Loading map...

Research Team

S

Simone Savastano, MD

A

Alessia Currao, PharmD (CRC)

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Danish Study to Assess the Efficacy of Implantable Cardiov...

Coronary Artery Disease

Actively Recruiting

1 location

Clinical Evaluation of Arrhythmia Mapping With a Paddle-shap...

Scar-related Atrial Tachycardia

Actively Recruiting

6 locations

Ablation-Index Guided Scar-Mediated Ventricular Tachycardia ...

Ventricular Tachycardia

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series.

Simone Savastano, Veronica Dusi, Enrico Baldi...

https://pubmed.ncbi.nlm.nih.gov/33190159

Percutaneous continuous left stellate ganglion block as an effective bridge to bilateral cardiac sympathetic denervation.

Simone Savastano, Luigi Pugliese, Enrico Baldi...

https://pubmed.ncbi.nlm.nih.gov/32034906

Percutaneous stellate ganglion block and extracorporeal cardiopulmonary resuscitation: an effective and safe combination for refractory ventricular fibrillation.

Simone Savastano, Enrico Baldi, Rita Camporotondo...

https://pubmed.ncbi.nlm.nih.gov/31257420

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva...

https://pubmed.ncbi.nlm.nih.gov/36017572